These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6108447)

  • 1. Erythrocyte glyceraldehyde-reductase levels in diabetics with retinopathy and cataract.
    Crabbe MJ; Peckar CO; Halder AB; Cheng H
    Lancet; 1980 Dec; 2(8207):1268-70. PubMed ID: 6108447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NADPH-oxidising activity in lens and erythrocytes in diabetic and nondiabetic patients with cataract.
    Crabbe MJ; Bron AJ; Peckar CO; Petchey M; Ting HH; Howard-Williams J
    Br J Ophthalmol; 1983 Oct; 67(10):696-9. PubMed ID: 6412739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes and diabetic retinopathy in patients undergoing cataract surgery: a prevalence study-DiCat study report #2.
    Rossi T; Panozzo G; Della Mura G; Giannarelli D; Ferrari D; Alessio G; Palmisano C; Telani S; Ripandelli G
    Acta Diabetol; 2020 Jun; 57(6):645-650. PubMed ID: 31912329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The sorbitol pathway in the human lens: aldose reductase and polyol dehydrogenase.
    Jedziniak JA; Chylack LT; Cheng HM; Gillis MK; Kalustian AA; Tung WH
    Invest Ophthalmol Vis Sci; 1981 Mar; 20(3):314-26. PubMed ID: 6782033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperglycemia-induced activation of human erythrocyte aldose reductase and alterations in kinetic properties.
    Srivastava SK; Ansari NH; Hair GA; Jaspan J; Rao MB; Das B
    Biochim Biophys Acta; 1986 Mar; 870(2):302-11. PubMed ID: 3082363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative importance of aldose reductase versus nonenzymatic glycosylation on sugar cataract formation in diabetic rats.
    Kador PF; Lee JW; Fujisawa S; Blessing K; Lou MF
    J Ocul Pharmacol Ther; 2000 Apr; 16(2):149-60. PubMed ID: 10803425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical localization for aldose reductase in diabetic lenses.
    Akagi Y; Kador PF; Kinoshita JH
    Invest Ophthalmol Vis Sci; 1987 Jan; 28(1):163-7. PubMed ID: 3100473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cataract and retinopathy: screening for treatable retinopathy.
    Bron AJ; Cheng H
    Clin Endocrinol Metab; 1986 Nov; 15(4):971-99. PubMed ID: 3096617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aldose reductase inhibitors and cataract.
    Crabbe MJ
    Int Ophthalmol; 1991 Jan; 15(1):25-36. PubMed ID: 1901300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High levels of erythrocyte aldose reductase and diabetic retinopathy in NIDDM patients.
    Nishimura C; Saito T; Ito T; Omori Y; Tanimoto T
    Diabetologia; 1994 Mar; 37(3):328-30. PubMed ID: 8174849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in the lens epithelium with respect to cataractogenesis: light microscopic and Scheimpflug densitometric analysis of the cataractous and the clear lens of diabetics and non-diabetics.
    Tkachov SI; Lautenschläger C; Ehrich D; Struck HG
    Graefes Arch Clin Exp Ophthalmol; 2006 May; 244(5):596-602. PubMed ID: 16175371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Aldose reductase inhibitor--a new way for preventing diabetic lens changes?].
    Ohrloff C; Hockwin O; Korte I; Wegener A
    Klin Monbl Augenheilkd; 1986 Nov; 189(5):361-2. PubMed ID: 3100860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of aldose reductase by nonenzymatic glycosylation.
    Srivastava SK; Ansari NH; Bhatnagar A; Hair G; Liu S; Das B
    Prog Clin Biol Res; 1989; 304():171-84. PubMed ID: 2506561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated and unactivated forms of human erythrocyte aldose reductase.
    Srivastava SK; Hair GA; Das B
    Proc Natl Acad Sci U S A; 1985 Nov; 82(21):7222-6. PubMed ID: 3933003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aldose reductase in diabetic cataracts.
    Kinoshita JH; Kador P; Catiles M
    JAMA; 1981 Jul; 246(3):257-61. PubMed ID: 6787220
    [No Abstract]   [Full Text] [Related]  

  • 16. NADPH-dependent reduction of glyceraldehyde: a unusually high activity in the lens of the camel (Camelus dromedarius).
    Del Corso A; Osman AM; Mohamed AS; Camici M; Barsacchi D; Tozzi MG; Mura U
    Boll Soc Ital Biol Sper; 1989 Mar; 65(3):235-42. PubMed ID: 2504255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aldose reductase in early streptozotocin-induced diabetic rat lens.
    Garadi R; Lou MF
    Invest Ophthalmol Vis Sci; 1989 Nov; 30(11):2370-5. PubMed ID: 2509397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Yellow discoloration of the lens in the diabetic patient].
    Menon SR; Dekker P; Robert Y
    Klin Monbl Augenheilkd; 1996 May; 208(5):275-8. PubMed ID: 8766025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aldose reductase and glutathione in senile cataract nucleus of diabetics and non-diabetics.
    Khare K; Mendonca T; Rodrigues G; Kamath M; Hegde A; Nayak S; Kamath A; Kamath S
    Int Ophthalmol; 2023 Oct; 43(10):3673-3680. PubMed ID: 37395905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Aldose reductase activity in clear and senile cataractous lenses].
    Du XY; Li SZ; Mao WS
    Yan Ke Xue Bao; 1986 Jun; 2(2):126-8. PubMed ID: 3147913
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.